MedPath

HIDROCLOROTIAZIDA SANDOZ 25 MG COMPRIMIDOS EFG

HIDROCLOROTIAZIDA SANDOZ 25 MG COMPRIMIDOS EFG

Commercialized
Register Number

86487

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Feb 21, 2022

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number86487
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

HIDROCLOROTIAZIDAActive
Quantity: 25 mg
Name: HIDROCLOROTIAZIDA

ATC CLASSIFICATION (3)

C03A
C03AA
C03AA03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.